Home > Insider Trading > Filing (0001179110-12-015223)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1158223	Affymax Inc	AFFY	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1344153	H Jeffrey Knapp	C/O Affymax, Inc. 4001 Miranda Ave. Palo Alto CA 94304	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-10-15	1,016	$6.23	14,141	No	4	M	Direct
Common Stock	Acquisiton	2012-10-15	312	$7.04	14,453	No	4	M	Direct
Common Stock	Acquisiton	2012-10-15	1,584	$10.99	16,037	No	4	M	Direct
Common Stock	Acquisiton	2012-10-15	3,750	$18.84	19,787	No	4	M	Direct
Common Stock	Acquisiton	2012-10-15	1,000	$21.74	20,787	No	4	M	Direct
Common Stock	Acquisiton	2012-10-15	2,350	$24.50	23,137	No	4	M	Direct
Common Stock	Disposition	2012-10-15	10,012	$26.71	13,125	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2012-10-15	1,016	$0.00	1,016	$6.23
Common Stock	Stock Option (Right to Buy)	Disposition	2012-10-15	312	$0.00	312	$7.04
Common Stock	Stock Option (Right to Buy)	Disposition	2012-10-15	1,584	$0.00	1,584	$10.99
Common Stock	Stock Option (Right to Buy)	Disposition	2012-10-15	3,750	$0.00	3,750	$18.84
Common Stock	Stock Option (Right to Buy)	Disposition	2012-10-15	1,000	$0.00	1,000	$21.74
Common Stock	Stock Option (Right to Buy)	Disposition	2012-10-15	2,350	$0.00	2,350	$24.50

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
22,344	2020-07-21	No	4	M	Direct
10,313	2021-07-10	No	4	M	Direct
2,266	2019-01-14	No	4	M	Direct
51,832	2016-07-27	No	4	M	Direct
7,000	2017-12-17	No	4	M	Direct
18,550	2020-01-06	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The shares were sold at prices ranging from $26.54 to $26.93. The reporting person will provide to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares vest and become exercisable in a series of forty-eight (48) successive equal monthly installments over the four (4) year period measured from July 22, 2010.
The shares vest and become exercisable in a series of forty-eight (48) successive equal monthly installments over the four (4) year period measured from July 11, 2011.
The shares vest and become exercisable in a series of forty-eight (48) successive equal monthly installments over the four (4) year period measured from January 1, 2009.
Fully vested.
The shares vest and become exercisable in a series of forty-eight (48) successive equal monthly installments over the four (4) year period measured from January 1, 2010.